text_1: A world first: AIDS vaccine cuts the risk of HIV infection by 31 percent in large Thai study
text_2: This was a very nicely written piece presenting the results of the first successful AIDS vaccination trial. Using an appropriately cautious tone, this story effectively informs the reader of the vaccine’s availability, novelty and efficacy. The story also does a good job of describing the study methods and accurately points out that the same results may not be seen in the U.S. given that study took place in Thailand where HIV is spread largely through heterosexual sex. Additionally, the expert commentary puts it nicely in perspective from a public health standpoint. While the story meets many of our criteria, it could have been improved by mentioning potential harms and making it clear that this research has not yet been published, and that others have raised questions about the lack of data and details that have been released.